A new generation toothpaste has some influence in reducing the levels of c-reactive protein thus reducing cardiac diseases.
WHAT IS C-REACTIVE PROTEIN?
The liver produces a protein called C-reactive protein and subsequently released in the bloodstream as a response to inflammation.
Higher levels of C-reactive protein in the bloodstream indicates the following:
- Systemic inflammations.
- Sepsis as a result of bacterial infections.
- Fungal infections.
- Infection affecting bones also.
- Inflammatory bowel disease – A disorder causing not only swelling but also internal bleeding of the intestines.
- Any chronic or autoimmune diseases.
This inflammatory marker – considered as a sensitive marker for indicating the risk of cardiac diseases caused by systemic inflammation.
LATEST RESEARCH FROM FLORIDA:
The researchers from Florida Atlantic University’s Schmidt College of Medicine, Marshfield Clinic Research Institute, and the University of Wisconsin School of Medicine and Public Health, collaborated on a randomized trial study based on the hypothesis involving the interrelationships between systemic inflammation, gum & its surrounding tissue disease and cardiac diseases.
TOOTHPASTE AND INFLAMMATION:
Researchers found a plaque identifying toothpaste which had some effects in reducing the levels of c-reactive protein. Plaque HD or an identical toothpaste has some effects in reducing the levels of heart attacks or strokes
There was a notable reduction not only in the levels of c-reactive protein but also the risk of cardiac events when monitored over a period of time.
Trial support the interrelationship with inflammation and cardiac diseases along with the levels of c-reactive protein.
But the researcher’s concluded that the reduction in c-reactive protein levels due to the plaque identifying toothpaste still needs a large scale trial to aid the future population.